Blog
RSS FeedPosted by Michael Wonder on 12 Apr 2025
Public Summary Documents – December 2024 PBAC meeting
11 April 2025 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the December 2024 PBAC ...
Posted by Michael Wonder on 27 Mar 2025
ICER publishes evidence report on treatment for retinitis pigmentosa
26 March 2025 - There are significant uncertainties regarding long term efficacy and durability of sonpiretigene isteparvovec; ICER estimates that ...
Posted by Michael Wonder on 21 Mar 2025
Public Summary Documents (first time rejections and deferrals)– November 2024 PBAC meeting
21 March 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2024 PBAC ...
Posted by Michael Wonder on 14 Mar 2025
DUSC utilisation analysis public release documents (October 2024)
14 March 2025 - The utilisation analysis public release documents from the October 2024 DUSC meeting are now available. ...
Posted by Michael Wonder on 07 Mar 2025
Public Summary Documents – November 2024 PBAC meeting
7 March 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2024 PBAC ...
Posted by Michael Wonder on 10 Feb 2025
ICER releases draft evidence report on treatment for advanced retinitis pigmentosa
6 February 2025 - Public comment period now open until 6 March 2025; requests to make oral comment during public ...
Posted by Michael Wonder on 10 Feb 2025
ICER publishes evidence report on treatment for acute pain
5 February 2025 - Current evidence suggests that suzetrigine may provide a net health benefit when compared to no systemic ...
Posted by Michael Wonder on 28 Dec 2024
Utilisation analysis of heart failure medicines listed on the PBS
20 December 2024 - At its September 2024 meeting, the PBAC considered a report presenting a utilisation analysis of PBS ...
Posted by Michael Wonder on 26 Dec 2024
PBS Expenditure and Prescriptions Report (2023-24)
19 December 2024 - The PBS Expenditure and Prescriptions Report 1 July 2023 to 30 June 2024 is now available. ...
Posted by Michael Wonder on 26 Dec 2024
Report on PBS/RPBS under co-payment prescriptions data (2023-24)
19 December 2024 - The Report on Under Co-payment Prescriptions Data (2023-24) is now available. ...
Posted by Michael Wonder on 24 Dec 2024
Public Summary Documents – September 2024 PBAC meeting
24 December 2024 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the September 2024 PBAC ...
Posted by Michael Wonder on 12 Dec 2024
ICER announces most significant drug price hikes unsupported by new clinical evidence in US
12 December 2024 - Of 10 high expenditure drugs that had substantial 2023 net price increases, five were not supported ...
Posted by Michael Wonder on 12 Dec 2024
Outcome statements for October 2024 stakeholder meetings: oral contraceptives and migraine
9 December 2024 - The Outcome Statements are now available for the Oral Contraceptives Stakeholder Meeting held on 10 October 2024 ...
Posted by Michael Wonder on 01 Dec 2024
DUSC utilisation analysis public release documents (June 2024) update
22 November 2024 - The utilisation analysis public release documents from the June 2024 DUSC meeting are now available. ...
Posted by Michael Wonder on 16 Nov 2024
Outcome statement - October 2024 DUSC meeting
15 November 2024 - The outcome statement from the October 2024 DUSC meeting is now available. ...